Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: A cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China))

British Journal of Nutrition

Volumn 115, Issue 8, 2016, Pages 1352-1359

  Zhai, Hua Ling ^a   Wang, Ning Jian ^a   Han, Bing ^a   Li, Qin ^a   Chen, Yi ^a   Zhu, Chun Fang ^a   Chen, Ying Chao ^a   Xia, Fang Zhen ^a   Cang, Zhen ^a   Zhu, Chao Xia ^a   Lu, Meng ^a   Lu, Ying Li ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

BMI; Homoeostasis model assessment; Insulin resistance; Non alcoholic fatty liver disease; Vitamin D

Indexed keywords

VITAMIN D;

ADULT; ARTICLE; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; PREVALENCE; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; AGED; BLOOD; COMPLICATION; DIAGNOSTIC IMAGING; ECHOGRAPHY; MIDDLE AGED; SEX FACTOR; STATISTICAL MODEL;

ADULT; AGED; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC DISEASES; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTORS; SEX FACTORS; ULTRASONOGRAPHY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84958746263     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114516000386     Document Type: Article

References (33)

1. Chalasani N, Younossi Z, Lavine JE, et al. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005-2023.
2. Williams CD, Stengel J, Asike MI, et al. (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140, 124-131.
3. Wong VW (2013) Nonalcoholic fatty liver disease in Asia: a story of growth. J Gastroenterol Hepatol 28, 18-23.
4. Mohamed AA, Mahmoud S, Ahmed R, et al. (2015) Vitamin D is it a key in Egyptian NAFLD pathogenesis J Gastroenterol Hepatol 4, 1605-1609.
5. Kong M, Zhu L, Bai L, et al. (2014) Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model. Am J Physiol Gastrointest Liver Physiol 307, G883-G893.
6. Rhee EJ, Kim MK, Park SE, et al. (2013) High serum Vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr J 60, 743-752.
7. Sharifi N, Amani R, Hajiani E, et al. (2014) Does Vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease A randomized clinical trial. Endocrine 47, 70-80.
8. Targher G, Scorletti E, Mantovani A, et al. (2013) Nonalcoholic fatty liver disease and reduced serum Vitamin D(3) levels. Metab Syndr Relat Disord 11, 217-228.
9. Bril F, Maximos M, Portillo-Sanchez P, et al. (2014) Relationship of Vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis. J Hepatol 62, 405-411.
10. Wang N, Kuang L, Han B, et al. (2015) Follicle-stimulating hormone associates with prediabetes and diabetes in postmenopausal women. Acta Diabetol (Epublication ahead of print version 12 May 2015).
11. Xu Y, Wang L, He J, et al. (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310, 948-959.
12. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28, 412-419.
13. Hamaguchi M, Kojima T, Takeda N, et al. (2007) Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 13, 1579-1584.
14. Ong JP & Younossi ZM (2007) Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 11, 1-16.
15. Ross AC, Manson JE, Abrams SA, et al. (2011) The 2011 report on dietary reference intakes for calcium and Vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab 96, 53-58.
16. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. (2011) Evaluation, treatment, and prevention of Vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96, 1911-1930.
17. Barchetta I, Angelico F, Del Ben M, et al. (2011) Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) Vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 9, 85.
18. Targher G, Bertolini L, Scala L, et al. (2007) Associations between serum 25-hydroxyVitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 17, 517-524.
19. Hao YP, Ma XJ, Luo YQ, et al. (2014) Serum Vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes. Acta Pharmacol Sin 35, 1150-1156.
20. Lu Z, Pan X, Hu Y, et al. (2015) Serum Vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women. Clin Exp Pharmacol Physiol 42, 139-145.
21. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911-919.
22. Hotamisligil GS, Shargill NS & Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
23. Roth CL, Elfers CT, Figlewicz DP, et al. (2012) Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activation. Hepatology 55, 1103-1111.
24. Sharifi N, Amani R, Hajiani E, et al. (2014) Does Vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease A randomized clinical trial. Endocrine 47, 70-80.
25. Wang N, Li Q, Han B, et al. (2015) Follicle-stimulating hormone is associated with non-alcoholic fatty liver disease in Chinese women over 55 years old. J Gastroenterol Hepatol (epublication ahead of print version 18 December 2015).
26. Wang N, Han B, Li Q, et al. (2015) Vitamin D is associated with testosterone and hypogonadism in Chinese men: results from a cross-sectional SPECT-China study. Reprod Biol Endocrinol 13, 74.
27. Kobyliak N & Abenavoli L (2014) The role of liver biopsy to assess non-alcoholic fatty liver disease. Rev Recent Clin Trials 9, 159-169.
28. Zhou W & Ye SD (2015) Relationship between serum 25-hydroxyVitamin D and lower extremity arterial disease in type 2 diabetes mellitus patients and the analysis of the intervention of Vitamin D. J Diabetes Res 2015, 815949.
29. Lim S, Kim MJ, Choi SH, et al. (2013) Association of Vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjects. Am J Clin Nutr 97, 524-530.
30. Mojiminiyi OA & Abdella NA (2010) Effect of homeostasis model assessment computational method on the definition and associations of insulin resistance. Clin Chem Lab Med 48, 1629-1634.
31. Ghasemi A, Tohidi M, Derakhshan A, et al. (2015) Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study. Acta Diabetol 52, 905-915.
32. Morimoto A, Tatsumi Y, Soyano F, et al. (2014) Increase in homeostasis model assessment of insulin resistance (HOMA-IR) had a strong impact on the development of type 2 diabetes in Japanese individuals with impaired insulin secretion: The Saku study. PLOS ONE 9, e105827.
33. Sarafidis PA, Lasaridis AN, Nilsson PM, et al. (2007) Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes. J Hum Hypertens 21, 709-716.